Sunday December 15, 2019
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Asia 2020
    • |BioProcess International US West
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

July 2005

Disposable Technology: Validation of a Novel Disposable Connector for Sterile Fluid Transfer

by BPI Contributor
Add Comment
July 1, 2005

Chemicals and Raw Materials: Resources

by BPI Contributor
Add Comment
July 1, 2005

Innovative Single-Use Mixing Systems

by BPI Contributor
Add Comment
July 1, 2005

From Gene Expression to Production: Cardinal Health Is the Right Partner for All of Your Biologic Product Needs

by BPI Contributor
Add Comment
July 1, 2005

Did You Say Disposable?

by BPI Contributor
Add Comment
July 1, 2005

BioReliance Testing and Manufacturing Services

by BPI Contributor
Add Comment
July 1, 2005

Hollow Fiber Membrane Separations: Gentle Process Filtration and Counter-Current Dialysis

by BPI Contributor
Add Comment
July 1, 2005

From Cell Line Optimization to Aseptic Filling: Cooperative Partnering for Every Phase of Clinical Trials Materials Development and Production

by BPI Contributor
Add Comment
July 1, 2005

Capture of Glycoproteins By Aminophenyl Boronate Affinity Chromatography

by BPI Contributor
Add Comment
July 1, 2005

Vaccine Manufacturing Case Study

by BPI Contributor
Add Comment
July 1, 2005
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • >

Editor’s Choice

  • BioProcess Insider

    $50m deal helps make Sartorius a media player again

  • BioProcess Insider

    Astellas: Large-scale gene therapy plant major driver in $3bn Audentes deal

  • Sponsored Content

    The Road to Commercialization: A Commercial CDMO’s Perspective

  • BioProcess Insider

    Blame the messenger: Novartis cites RNAi candidate in $9.7bn Medicines Company deal

  • BioProcess Insider

    China: Stainless-steel will shine as market moves to commercial

  • Sponsored Content

    Matrix: The Highly Automated Multibioreactor Solution That Fits to Your Bench Space, Bioprocessing Needs, and Budget

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: The US Government has contracted Sanofi Pasteur to increase recombinant #vaccine capacity at its Pennsylvania plant… https://t.co/hWSs4TUnZT 3 days ago
  • Tweet Avatar RT @BioProcessIntl: Webcast: "Best Practices for Aseptic Sampling from Stainless Process Equipment" December 19th, 2019 at 11:00 AM ET… https://t.co/lsbrHcpwBy 3 days ago
  • Tweet Avatar RT @Dan5tanton: A single-use bioprocessing training facility in Guangzhou will help attract and retain biopharma talent in the burg… https://t.co/IaN6DEcrwB 4 days ago
  • Tweet Avatar RT @Dan5tanton: @Amazon says Novartis’ personalized medicines operations will benefit from AI and machine learning collaboration. https://t.co/ckQrFpJ4aX 5 days ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    MilliporeSigma: Over 90% growth comes from mAbs, despite new modality momentum

  • BioProcess Insider

    Fujifilm pumps $120m into US gene therapy development and manufacturing

  • BioProcess Insider

    $50m deal helps make Sartorius a media player again

  • BioProcess Insider

    Purolite resin booming on biopharma uptake and ‘major’ regulatory milestone

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2019 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    ▼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    ▼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    ▼
    • BioProcess International Asia 2020
    • BioProcess International US West
  • BioProcess International Academy
  • Events